Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinician-reviewed guide to delayed-onset side effects of dapagliflozin (Farxiga), including Fournier's gangrene, DKA, bone fractures, and bladder cancer signals, with trial data, FAERS reports, and dose timelines.
Read clinical reviewA comprehensive breakdown of dapagliflozin (Farxiga) adverse event rates drawn from DECLARE-TIMI 58, DAPA-HF, DAPA-CKD, FAERS reports, and the FDA prescribing label, with specific incidence numbers for every major side effect.
Read clinical reviewA physician-reviewed guide to Farxiga (dapagliflozin) side effects that may become permanent, including Fournier's gangrene, DKA, and kidney injury, with trial data, FDA warnings, and clinical guidance.
Read clinical reviewA clinician-reviewed guide to the rare but serious adverse events linked to Farxiga (dapagliflozin), including DKA, Fournier gangrene, necrotizing fasciitis, and urosepsis. Backed by trial data, FDA labeling, and post-market surveillance.
Read clinical reviewA clinician-reviewed breakdown of Farxiga (dapagliflozin) adverse events by severity and patient phenotype, drawing on DECLARE-TIMI 58, DAPA-HF, DAPA-CKD, FDA labeling, and FAERS data.
Read clinical reviewDoes stopping Farxiga (dapagliflozin) cause withdrawal? Learn what happens when you discontinue the drug, which side effects emerge, how to taper safely, and what the clinical evidence actually shows.
Read clinical review